Association Between Alpha-2a-adrenergic Receptor Gene and ADHD Inattentive Type

Biological Psychiatry

Volumn 60, Issue 10, 2006, Pages 1028-1033

  Schmitz, Marcelo ^a   Denardin, Daniel ^a   Silva, Tatiana Laufer ^a   Pianca, Thiago ^a   Roman, Tatiana ^c   Hutz, Mara Helena ^b   Faraone, Stephen V ^d   Rohde, Luis Augusto ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Federal School of Medical Sciences of Porto Alegre   (Brazil)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

ADRA2A gene; adrenergic receptors; attention deficit hyperactivity disorder inattentive type; candidate genes; children; molecular genetics

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR;

AGE DISTRIBUTION; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; RECEPTOR GENE; SAMPLE (STATISTICS); SEX RATIO; STATISTICAL ANALYSIS; STRUCTURED INTERVIEW;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC, ALPHA-2; SEVERITY OF ILLNESS INDEX;

EID: 33750458363     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.02.035     Document Type: Article

References (51)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Arnsten A.F., Steere J.C., and Li B.M. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 1 57 (2005) 1377-1384
3. Arnsten A.F., Steere J.C., and Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53 (1996) 448-455
4. Associação Brasileira de Empresas de Pesquisa (2003): Critério de classificação econômica Brasil. Available at: http://www.anep.org.br/codigosguias/CCEB.pdf . Accessed April 18, 2005.
5. Belfer I., Buzas B., Hipp H., Phillips G., Taubman J., Lorinczi I., et al. Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. J Hum Genet 50 (2005) 12-20
6. Ben Amor L., Grizenko N., Schwartz G., Lageix P., Baron C., and Ter-Stepanian M. Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci 30 (2005) 120-126
7. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
8. Biederman J., Faraone S.V., Monuteaux M.C., Bober M., and Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry 55 (2004) 692-700
9. Biederman J., and Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46 (1999) 1234-1242
10. Bobb A.J., Addington A.M., Sidransky E., Gornick M.C., Lerch J.P., Greenstein D.K., et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 134 (2005) 67-72
11. Brito G.N., Pereira C.C., and Santos-Morales T.R. Behavioral and neuropsychological correlates of hyperactivity and inattention in Brazilian school children. Dev Med Child Neurol 41 (1999) 732-739
12. Comings D.E., Gade-Andavolu R., Gonzalez N., Blake H., Wu S., and MacMurray J.P. Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 55 (1999) 160-172
13. Corrêa-Filho A.G., Bodanese R., Silva T.L., Alvares J.P., Aman M., and Rohde L.A. Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. J Am Acad Child Adolesc Psychiatry 44 (2005) 748-755
14. Crowe R.R. Candidate genes in psychiatry: An epidemiological perspective. Am J Med Genet 48 (1993) 74-77
15. Curtis D., and Sham P.C. A note on the application of the transmission disequilibrium test when a parent is missing. Am J Hum Genet 56 (1995) 811-812
16. Eiraldi R.B., Power T.J., and Nezu C.M. Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children. J Am Acad Child Adolesc Psychiatry 36 (1997) 503-514
17. Ewens W.J., and Spielman R.S. The transmission/disequilibrium test: History, subdivision, and admixture. Am J Hum Genet 57 (1995) 455-464
18. Faraone S.V., Biederman J., Weber W., and Russell R.L. Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: Results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry 37 (1998) 185-193
19. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1313-1323
20. Faraone S.V., Sergeant J.A., Gillberg C., and Biederman J. The worldwide prevalence of ADHD: Is it an American condition?. World Psychiatry 2 (2003) 104-113
21. Franowicz J.S., and Arnsten A.F. The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys. Psychopharmacology (Berl) 136 (1998) 8-14
22. Gansler D.A., Fucetola R., Krengel M., Stetson S., Zimering R., and Makary C. Are there cognitive subtypes in adult attention deficit/hyperactivity disorder?. J Nerv Ment Dis 186 (1998) 776-781
23. Gaub M., and Carlson C.L. Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population. J Abnorm Child Psychol 25 (1997) 103-111
24. Hosmer D., and Lemeshow S. Applied Logistic Regression (2000), Wiley-Interscience, Hoboken, NJ
25. Hudziak J.J., Heath A.C., Madden P.F., Reich W., Bucholz K.K., Slutske W., et al. Latent class and factor analysis of DSM-IV ADHD: A twin study of female adolescents. J Am Acad Child Adolesc Psychiatry 37 (1998) 848-857
26. Huizink A.C., and Mulder E.J. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 30 (2006) 24-41
27. Jakala P., Riekkinen M., Sirvio J., Koivisto E., Kejonen K., Vanhanen M., et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology 20 (1999) 460-470
28. Lahiri D.K., and Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMV DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
29. Lario S., Calls J., Cases A., Oriola J., Torras A., and Rivera F. MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. Clin Genet 51 (1997) 129-130
30. Orvaschel H. Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull 21 (1985) 737-745
31. Park L., Nigg J.T., Waldman I.D., Nummy K.A., Huang-Pollock C., Rappley M., et al. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10 (2004) 572-580
32. Paternite C.E., Loney J., and Roberts M.A. A preliminary validation of subtypes of DSM-V attention deficit hyperactivity disorder. J Atten Disord 1 (1996) 70-86
33. Polanczyk G.V., Eizirik M., Aranovich V., Denardin D., da Silva T.L., da Conceicao T.V., et al. Interrater agreement for the schedule for affective disorders and schizophrenia epidemiological version for school-age children (K-SADS-E). Rev Bras Psiquiatr 25 (2003) 87-90
34. Rohde L.A. ADHD in a developing country: Are DSM-IV criteria suitable for culturally different populations?. J Am Acad Child Adolesc Psychiatry 41 (2002) 1131-1133
35. Rohde L.A., Barbosa G., Polanczyk G., Eizirik M., Rasmussen E.R., Neuman R.J., et al. Factor and latent class analysis of DSM-IVADHD symptoms in a school sample of Brazilian adolescents. J Am Acad Child Adolesc Psychiatry 40 (2001) 711-718
36. Rohde L.A., Biederman J., Busnello E.A., Zimmermann H., Schmitz M., Martins S., et al. ADHD in a school sample of Brazilian adolescents: A study of prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry 38 (1999) 716-722
37. Rohde L.A., Szobot C., Polanczyk G., Martins S., Schmitz M., and Tramontina S. ADHD in a diverse culture: Do research and clinical findings support the notion of a cultural construct for the disorder?. Biol Psychiatry 57 (2005) 1436-1441
38. Roman T., Polanczyk G., Zeni C., Genro J., Rohde L.A., Hutz M., et al. Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of ADHD. Mol Psychiatry 11 (2006) 8-10
39. Roman T., Schmitz M., Polanczyk G.V., Eizirik M., Rohde L.A., and Hutz M.H. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 114 (2002) 154-158
40. Roman T., Schmitz M., Polanczyk G.V., Eizirik M., Rohde L.A., and Hutz M.H. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?. Am J Med Genet B Neuropsychiatr Genet 120 (2003) 116-120
41. Shaffer D., Gould M.S., Brasic J., Ambrosini P., Fisher P., Bird H., et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry 40 (1983) 1228-1231
42. State M.W., Lombroso P.J., Pauls D.L., and Leckman J.F. The genetics of childhood psychiatric disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry 39 (2000) 946-962
43. Stevens J., Quittner A.L., and Abikoff H. Factors influencing elementary school teachers' rating ADHD and ODD behaviors. J Clin Child Psychol 27 (1998) 406-414
44. Stevenson J., Langley K., Pay H., Payton A., Worthington J., Olliver W., et al. Attention deficit hyperactivity disorder with reading disabilities: Preliminary genetic findings on the involvement of the ADRA2A gene. J Child Psychol Psychiatry 46 (2005) 1081-1088
45. Swanson J.M., Kraemer H.C., Hinshaw S.P., Arnold L.E., Conners C.K., Abikoff H.B., et al. Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40 (2001) 168-179
46. Talmud P.J., and Humphries S.E. Genetic polymorphisms, lipoproteins and coronary artery disease risk. Curr Opin Lipidol 12 (2001) 405-409
47. Terwilliger J.D., and Ott J. A haplotype-based "haplotype relative risk" approach to detecting allelic associations. Hum Hered 42 (1992) 337-346
48. Wang B., Wang Y., Zhou R., Li J., Qian Q., Yang L., et al. Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 130-134
49. Wechsler D. WISC III/Manual (1991), Psychological Corporation, New York, NY
50. Woo B.S., and Rey J.M. The validity of the DSM-IV subtypes of attention-deficit/hyperactivity disorder. Aust N Z J Psychiatry 39 (2005) 344-353
51. Xu C., Schachar R., Tannock R., Roberts W., Malone M., Kennedy J.L., et al. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 105 (2001) 159-162